Ellevest, Inc. Novo Nordisk A S Transaction History

Ellevest, Inc.

$1.72 Billion
Q4 2024

A detailed history of Ellevest, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Ellevest, Inc. holds 22,644 shares of NVO stock, worth $1.32 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

22,644

Previous 23,468 3.51%

Holding current value

$1.32 Million

Previous $2.79 Million 30.31%

% of portfolio

0.11%

Previous 0.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $70,040 - $98,912	-824 Reduced 3.51%	22,644 $1.95 Million
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $42,507 - $51,914	357 Added 1.54%	23,468 $2.79 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $148,847 - $178,201	1,213 Added 5.54%	23,111 $3.3 Million
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $40,027 - $53,280	392 Added 1.82%	21,898 $2.81 Million
Q4 2023 Feb 06, 2024	BUY	$87.78 - $105.45 $10,709 - $12,864	122 Added 0.57%	21,506 $2.22 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $1.05 Million - $2.3 Million	11,550 Added 117.45%	21,384 $1.94 Million
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $28,232 - $31,249	181 Added 1.88%	9,834 $1.59 Million
Q1 2023 May 04, 2023	SELL	$132.34 - $159.14 $5,028 - $6,047	-38 Reduced 0.39%	9,653 $1.54 Million
Q4 2022 Feb 03, 2023	BUY	$102.55 - $135.33 $173,309 - $228,707	1,690 Added 21.12%	9,691 $1.31 Million
Q3 2022 Nov 02, 2022	SELL	$95.28 - $116.93 $143,682 - $176,330	-1,508 Reduced 15.86%	8,001 $797,000
Q2 2022 Jul 18, 2022	BUY	$103.24 - $121.81 $93,948 - $110,847	910 Added 10.58%	9,509 $1.06 Million
Q1 2022 Apr 19, 2022	BUY	$93.1 - $112.54 $181,172 - $219,002	1,946 Added 29.25%	8,599 $955,000
Q4 2021 Jan 24, 2022	BUY	$95.88 - $117.08 $27,325 - $33,367	285 Added 4.48%	6,653 $745,000
Q3 2021 Oct 19, 2021	BUY	$84.42 - $106.62 $70,237 - $88,707	832 Added 15.03%	6,368 $611,000
Q2 2021 Jul 13, 2021	BUY	$67.66 - $84.76 $66,915 - $83,827	989 Added 21.75%	5,536 $464,000
Q1 2021 May 03, 2021	BUY	$67.06 - $75.82 $28,165 - $31,844	420 Added 10.18%	4,547 $307,000
Q4 2020 Feb 04, 2021	BUY	$63.89 - $73.8 $90,787 - $104,869	1,421 Added 52.51%	4,127 $288,000
Q3 2020 Oct 26, 2020	SELL	$63.69 - $70.22 $4,330 - $4,774	-68 Reduced 2.45%	2,706 $188,000
Q2 2020 Jul 06, 2020	BUY	$58.54 - $67.94 $48,763 - $56,594	833 Added 42.92%	2,774 $182,000
Q1 2020 Apr 13, 2020	BUY	$49.46 - $64.78 $63,655 - $83,371	1,287 Added 196.79%	1,941 $117,000
Q4 2019 Feb 05, 2020	BUY	$49.86 - $58.26 $30,963 - $36,179	621 Added 1881.82%	654 $38,000
Q3 2019 Oct 08, 2019	SELL	$47.54 - $53.43 $6,703 - $7,533	-141 Reduced 81.03%	33 $2,000
Q2 2019 Aug 20, 2019	BUY	$46.79 - $52.47 $8,141 - $9,129	174 New	174 $9,000

Others Institutions Holding NVO

# of Institutions

1,869

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $131B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account